Jeff Ives, Ph.D.
CEO of Satori and a member of the Satori Board of Directors
Jeff joined Satori as CEO in 2008. Jeff has over 32 years of experience leading teams to discover important new clinical candidates and products. He has led CNS and oncology teams that have discovered greater than 50 clinical candidates including multiple new products such as Geodon®, Chantix® and Tarceva®, and was a co-leader of in-licensing teams for Pfizer products including Celebrex®, Bextra®, and Aricept®. Jeff was a Senior Vice President during two mergers and two major restructurings at Pfizer Global Research & Development. Most recently, he was the SVP and head Pfizer portfolio leader, leading the optimization of the entire global research candidate portfolio. Prior to that position, he was the SVP of the new Pharmacokinetics, Dynamics & Metabolism organization in Pfizer and VP of CNS Discovery.